Rare Disease Day - Clinical Gene Therapy: The Future is Now

Rare Disease Day is an annual observance to raise awareness for diseases that otherwise would not receive the recognition that they deserve. The day serves to improve access to medical treatments and research for patients and their families.


This year's program, Clinical Gene Therapy: The Future is Now, will feature a poster session followed by a panel of patients and a clinician.

James M. Wilson, MD, PhDDirector of the Orphan Disease Center at the University of Pennsylvania will serve as this year's keynote speaker.

Research Poster Abstract Submission

Research poster abstract submissions will be accepted on basic, translational, and clinical research related to rare diseases and their treatments.

RSVP and Abstract Submission


Friday, March 1st, 2019
11:00am to 2:30pm


Graduate Hotel, Minneapolis, MN


Patient Advocacy Group Breakfast

Poster Session
Research posters related to rare diseases or orphan drug research from investigators and their trainees




Co-Sponsors of Rare Disease Day

University of Minnesota Medical School, Stem Cell Institute
Center of Orphan Drug Research


ja logo

In support of improving patient care, University of Minnesota, Interprofessional Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation Statements

American Medical Association (AMA)

This activity has been approved for AMA PRA Category 1 Credit™. Determination of exact number of credits is pending.

Accreditation Council for Pharmacy Education (ACPE)

This activity is eligible for ACPE credit; see final CPE activity announcement for specific details.

Other Healthcare Professionals

Other healthcare professionals who participate in this CE activity may submit their statement of participation to their appropriate accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity meets the requirements for acceptable continuing education.